Back to
Wells Fargo & Company
AGRX
Showing 0 of 4 quarters
Position history for
Wells Fargo & Company's holdings in AGILE THERAPEUTICS INC
No. Wells Fargo exited its AGRX (Agile Therapeutics) position in Q1 2024. Its Q4 2023 13F listed 19 shares worth $37. Wells Fargo first reported AGRX in Q2 2023 and held it in 3 quarterly 13F filings.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
—
No position history available for this security.
Other major holders of AGRX: Renaissance Technologies LLC, Citadel Advisors LLC, Geode Capital Management, LLC, State Street Corp.